DNA X Inc. enters securities purchase agreement with private investors

DNA X, Inc. (formerly Sonim Technologies) executed a Securities Purchase Agreement dated May 20, 2026, to sell securities to private purchasers under Regulation D exemption. The transaction includes conversion of a $1.2 million bridge note and termination of a put option under a related membership interest purchase agreement.